Ticker
ELDNCompany Name
ELEDON PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 144.91M | $ 5.74M | 3.96% |
3/31/2025 | $ 161.31M | $ 8.5M | 5.27% |
12/31/2024 | $ 177.41M | $ 20.55M | 11.58% |
9/30/2024 | $ 114.58M | $ 6.75M | 5.89% |
6/30/2024 | $ 120.48M | $ 26.04M | 21.61% |
3/31/2024 | $ 80.82M | $ 5.66M | 7% |
12/31/2023 | $ 89.07M | $ 4.61M | 5.18% |
9/30/2023 | $ 96.07M | $ 3.67M | 3.82% |
6/30/2023 | $ 106.78M | $ 40.95M | 38.35% |
3/31/2023 | $ 82.31M | $ 46.48M | 56.48% |
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ELEDON PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 114.46M ] / Assets [ $ 192.59M ]
(=) Cash to Assets [ 59.44% ]
Minimum
Sep 30, 2023
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |